Apellis Pharmaceuticals

Apellis Pharmaceuticals

Global biopharma company leveraging courageous science, creativity, and compassion to deliver life-changing therapies.

Location
Roles tracked
0
In pipeline
0
Tracking since

At a glance

You're tracking 0 roles at Apellis Pharmaceuticals. Track a role to start building momentum here.

Company intel

From the job board · LinkedIn data via posting sync
Industry
Biotechnology Research
Company size
561 people
Headquarters
Waltham, MA +2 more
Founded
2008
Type
Public Company
Total funding
$919.6M

Apellis is now part of Biogen. Please follow along there for the latest news. In the coming weeks, this page will no longer be updated or monitored.

Targeted C3 Therapies Complement System Hematology Ophthalmology Nephrology Paroxysmal Nocturnal Hemoglobinuria (PNH) Geographic Atrophy (GA) C3 Glomerulopathy (C3G) Gene Therapy and Neurology

Open roles at Apellis Pharmaceuticals